Cellectar Biosciences is based in Florham Park, New Jersey. It has raised $103M in total funding. Latest round: Growth.
Cellectar Biosciences is based in Florham Park, New Jersey. Cellectar Biosciences has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in September 2023. The round record for Cellectar Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Rosalind Advisors, AIGH Capital, ADAR1, Second Line, Nantahala Capital, AuGC. 6 distinct backers are named across the disclosed rounds.
We update the Cellectar Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Florham Park and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide